Skip Navigation | ANU Home | Search ANU | Directories

Associate Professor Emily Banks B Med Sci (Hons) (Monash) MB BS (Hons) (Monash) PhD (London) Current Position: NHMRC Fellow and Scientific Director, The 45 and Up Study Contact Details: (Building 62, ANU map) National Centre for Epidemiology and Population Health The Australian National University Canberra, ACT, 0200 Australia T: +61 2 6125 0328 F: +61 2 6125 0740 Email

Research Interests

• large scale cohort studies
• pharmacoepidemiology
• hormone replacement therapy
• breast cancer screening
• fracture
• obesity and physical activity
  

Selected Recent Publications

Banks E, Canfell K. Invited commentary: Hormone therapy risks and benefits – The Women’s Health Initiative findings and the postmenopausal estrogen timing hypothesis. American Journal of Epidemiology 2009; 174:24-8

Banks E; lead and corresponding author for 45 and Up Study Collaborators. Cohort profile: The 45 and Up Study. International Journal of Epidemiology  2008; 37: 941 - 947.

Canfell K, Banks E, Myat Moa A, Beral V. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 2008;188: 614-644.

Banks E, Reeves G. Pregnancy in women with a history of breast cancer. British Medical Journal 2007;334:166-167.

Banks E; lead author for WHO study group on Female Genital Mutilation and Obstetric Outcome. Female genital mutilation and obstetric outcome: WHO collaborative prospective study in six African countries. Lancet 2006;367:1835-1841.

Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, Hilton E, Bailey S, Barrett N, Briers P, English R, Jackson A, Kutt E, Lavelle J, Rockall L, Wallis MG, Wilson M, Patnick J. Impact of use of hormone replacement therapy on false positive recall in the National Health Service Breast Screening Programme: population-based prospective study. British Medical Journal, 2004;328:1291-1292.

Banks E, Beral V, Reeves G, Balkwill A, Barnes I, for the Million Women Study Collaborators. Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. Journal of the American Medical Association, 2004;291:2212-2220.

Banks E, Beral V, Reeves G, Bull D; writing group for the Million Women Study Collaborators.  Breast cancer and hormone-replacement therapy in the Million Women Study.  Lancet 2003; 362:419-427.

Collaborative Group on Hormonal Factors in Breast Cancer (includes Banks E). Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 2002;360:87-195.

Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, Hilton E, Bailey S, Barrett N, Briers P , English R, Jackson A, Kutt E, Lavelle J, Rockall L, Wallis MG, Wilson M. Predictors of screening outcome in the National Health Service Breast Screening Programme. Journal of Medical Screening 2002;9:74-82.

Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942-44.

Banks E. Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review. Journal of Medical Screening 2001;8:29-35.

Banks E, Berrington A, Casabonne D. Overview of the relationship between use of progestogen-only contraceptives and bone mineral density. Br J Obstet Gynaecol 2001;108:1214-1221.